Indivior Pharmaceuticals, Inc. 4

Chief Accounting Officer Anderson Woodrow D bought 1,500 shares of Indivior Pharmaceuticals, Inc. common stock at about $35.69 per share on 2026-08-27.

On August 27, 2026, Anderson Woodrow D, Chief Accounting Officer of Indivior Pharmaceuticals, Inc., purchased 1,500 shares of the company’s common stock at a price of $35.69 per share, for an estimated total cost of approximately $53,535. Following this open‐market purchase, his directly held ownership increased to 27,638 shares of common stock. This transaction represents a discretionary insider purchase rather than a routine equity award or automatic transaction, and modestly increases the officer’s economic exposure to the company.

Filing Facts

CIK

1625297

Ticker

INDV

Form

4

Source Type

fda

Accession

0002014440-26-000012

Alert Tier

6